Flavia Machado
Federal University of São Paulo
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Flavia Machado as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:20 UTC. Open this list on ClinicalTrials.gov
- N/ANCT06227702 · Vexus-guided Fluid Management in Patients With Septic Shock After the Resuscitation PhaseFederal University of São Paulo · unknown · Critically Ill Patients, Septic Shock · principal investigator
- Ph2NCT05953142 · Use of Dobutamine in Patients With Sepsis and Maintained Hypoperfusion After Initial Volemic Resuscitation.Federal University of São Paulo · unknown · Sepsis, Hypoperfusion, Hyperlactatemia · study chair
- Ph4NCT02519699 · Microcirculation After MAP Increase in Septic Shock Patients With Previous HypertensionFederal University of São Paulo · completed · Septic Shock · study chair
- Ph2NCT01784159 · ASpirin for Patients With SEPsis and SeptIc ShockFederal University of São Paulo · terminated · Sepsis · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 01:20 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 01:20 UTC. The ranking covers the 200 most relevant of 74 PubMed records, and a shared surname and initials can bring in a namesake. All 74 on PubMed
- 966 citationsRCR 45.6
- 786 citationsRCR 37.4
- 740 citationsRCR 32.2
- Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial.J Vasc Surg · 2004405 citationsRCR 11.0
- 387 citationsRCR 22.2
- ENHANCE: results of a global open-label trial of drotrecogin alfa (activated) in children with severe sepsis.Pediatr Crit Care Med · 2006326 citationsRCR 10.2
- 306 citationsRCR 17.0
- 241 citationsRCR 10.9
- 175 citationsRCR 9.9
- Prognostic indicators in venous ulcers.J Am Acad Dermatol · 2000155 citationsRCR 6.3